Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6
Show Display Options
Rank Status Study
1 Recruiting Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
Conditions: Cardiomyopathy, Hypertrophic;   Cardiomyopathy, Hypertrophic, Familial
Intervention: Drug: Perhexiline

Study has passed its completion date and status has not been verified in more than two years.